Lts Lohmann Therapie-systeme Ag

Rolf Pracht

Christoph Schmitz

Mohammad Sameti

Andreas Koch

Andreas Henning

Michael Horstmann

Thomas Hille

Bodo Asmussen

Stefan Henke

Gabriel Wauer

Heiko Spilgies

Sebastian Scherr

Yves-Thorsten Przybylla

Danny Brodkorb

The invention relates to a microneedle array, in particular to an applicator system, and to the use thereof for the intradermal delivery of active ingredients in the form of salts, in particular medicinal drugs in the form of salts, wherein this microneedle array is suitable for penetrating the skin of humans or animals, and the microneedles are made of a formulation, containing at least one active ingredient in the form of a salt and at least one biodegradable polymer.

Microneedle array having an active ingredient in the form of salts

The present invention relates to a microneedle system (MNS) for the intradermal delivery of interferon, wherein polyvinylpyrrolidone is the major constituent of a completely soluble formulation.

Microneedle system for applying interferon

The invention relates to a transdermal therapeutic system for the controlled release of water-soluble pharmaceutical active ingredients from an aqueous phase, comprising an occlusive back layer, a central device facing the skin for releasing the agent, an adhesive layer concentrically surrounding the dispensing device and a removable protective film. Said device is made from a stationary solid phase and a liquid phase containing the active ingredient in aqueous solution, the solid phase being formed from a solid with a fleecy or spongy structure.

Transdermal therapeutic system for administering water-soluble peptides and polypeptides

A transdermal therapeutic system for administering lipophilic, poorly water-soluble and/or sparingly skin-permeable pharmaceutical active substances. The active substance is present in a multi-component enhancer system consisting of 4 components and each component of the multi-component enhancer system is selected from a different one of the substance groups: a) terpenes, b) cyclic glucitol ethers, c) medium-chain triglycerides of capric and caprylic acid and/or of linoleic acid; and d) longer-chain alcohols having a chain length of 8 or more carbon atoms.

Transdermal therapeutic system for administering lipophilic and/or sparingly skin-permeable active substances

A transdermal therapeutic system for administering lipophilic, poorly water-soluble and/or sparingly skin-permeable pharmaceutical active substances. The active substance is present in a multi-component enhancer system consisting of 4 components and each component of the multi-component enhancer system is selected from a different one of the substance groups:

Transdermal therapeutic system for administering lipophilic and/or sparingly skin- permeable active substances

Growing community of inventors

Höhr-Grenzhausen, Germany

Rolf Pracht